Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old
Clinical trial NCT05518201 · COMPLETED
Trial details
- NCT number
- NCT05518201
- Sponsor
- Shanghai Bovax Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2023-11-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.